The long march to surrogates of meaningful clinical outcomes in MS trials Are we there yet?

ArticleinNeurology 77(18):1658-9 · November 2011with3 Reads
Impact Factor: 8.29 · DOI: 10.1212/WNL.0b013e3182364a63 · Source: PubMed